Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2007
06/06/2007CN1974555A Process of producing pyridine product with content greater than 99%
06/06/2007CN1319975C Camptothecin analogs and methods of preparation thereof
06/06/2007CN1319965C 2-heteroaryl-3,4-dihydro-2H-pyrrole derivatives and use thereof as pesticides
06/06/2007CN1319962C 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
06/06/2007CN1319947C 4-aminopyridine preparation method
06/06/2007CN1319946C Novel 2-pyridylethylbenzamide derivative
06/06/2007CN1319644C Supported catalyst for pyridine synthesis by tetrahydrofurfuryl alcohol and preparation process thereof
06/05/2007USRE39682 Enzyme inhibitors, for cancer therapy
06/05/2007US7227035 Bis-aryl sulfonamides
06/05/2007US7227034 Formylating a halogenated 4-aminobiphenyl by a Vilsmeier reaction, acidification by a Knoevenagel or Doebner condensation reaction, and hydrogenation; shorter synthesis route; further modifications with siloxane moiety for charge transport layers in electrographic devices
06/05/2007US7227025 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine
06/05/2007US7226950 Sodium channel modulators
06/05/2007US7226944 As antitumor agent
06/05/2007US7226936 Pyridinic sulfonamide derivatives method of production and use thereof
06/05/2007US7226935 Hypoglycemic agent
06/05/2007CA2269561C Naphthalene derivative and liquid crystal composition comprising the same
06/05/2007CA2233298C Wood-protecting agent
06/05/2007CA2225624C Hydrazine derivatives
06/05/2007CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
05/2007
05/31/2007WO2007061360A2 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
05/31/2007WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions
05/31/2007WO2007060484A1 Azetidine derivatives as glyt1 inhibitors
05/31/2007WO2007060215A2 (r)-arylkylamino derivatives and pharmaceutical compositions containing them
05/31/2007WO2007060166A1 New n-phenethylcarboxamide derivatives
05/31/2007WO2007060164A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
05/31/2007WO2007060026A1 Urea derivatives useful as calcium receptor modulators
05/31/2007WO2007059872A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
05/31/2007WO2007027651A3 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
05/31/2007WO2007022964A3 Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors
05/31/2007WO2007017687A3 Ep2 receptor agonists
05/31/2007WO2006069388A3 Stabilized polymeric thiol reagents
05/31/2007WO2006058700A8 Acetamide compounds as fungicides
05/31/2007WO2005099688A3 Cyclic compounds
05/31/2007US20070123670 Dithioester chain transfer agents for use in reversible addition fragmentation chain transfer (RAFT) polymerization of acrylamide monomers; low polydispersity
05/31/2007US20070123551 Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders
05/31/2007US20070123513 6-thiomorpholin-4-yl-pyridine-3-sulfonic acid 4-chloro-2-methoxy-benzoylamide; ammonium salt of3-methyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-sulfonic acid 4-chloro-2-methoxy-benzoylamide; anticarcinogenic agent
05/31/2007US20070123512 Propionamide derivatives useful as androgen receptor modulators
05/31/2007US20070123509 Carboxamide derivatives
05/31/2007US20070123493 Benzamide derivative
05/31/2007CA2630860A1 Urea derivatives useful as calcium receptor modulators
05/31/2007CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions
05/31/2007CA2630039A1 Azetidine derivatives as glyt1 inhibitors
05/31/2007CA2629935A1 (r)-arylalkylamino derivatives and pharmaceutical compositions containing them
05/31/2007CA2629544A1 Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
05/30/2007EP1790638A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity
05/30/2007EP1789633A2 Benzamide compounds
05/30/2007EP1789410A1 Methylene dipiperidine derivatives
05/30/2007EP1789393A2 Pyridinylamines
05/30/2007EP1789392A2 Preparation of pyridonecarboxylic acid antibacterials
05/30/2007EP1789391A1 Bivalent linkers and conjugates thereof
05/30/2007EP1789390A2 Pyridyl inhibitors of hedgehog signalling
05/30/2007EP1789044A1 Phenylaminopyridines
05/30/2007EP1789041A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors
05/30/2007EP1603923B1 Metal complexes
05/30/2007EP1562940B1 Aryl sulfonamides
05/30/2007EP1411053B1 Method for obtaining derivatives of (pyridil substituted)methyl|thio|benzimidazol
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007CN1972960A Processes for preparing eptifibatide
05/30/2007CN1972925A Substituted bisarylurea derivatives
05/30/2007CN1972922A 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi
05/30/2007CN1972914A Non-imidazole heterocyclic compounds as histamine H3-receptor ligands
05/30/2007CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
05/30/2007CN1972908A N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
05/30/2007CN1972898A Process for the preparation of enantiomerically enriched beta amino acid derivatives
05/30/2007CN1972897A Novel hexafluoroisopropanol derivatives
05/30/2007CN1972884A Molecularly imprinted polymers selective for nitrosamines and methods of using the same
05/30/2007CN1970559A Beta-carboline alkaloid, their preparation method and use
05/30/2007CN1970553A 5-amido-2-[(4-methoxyl-3-methyl-2-pyridinyl)-methylthio]-1-hydro-benzimidazole and its derivative synthesis method
05/30/2007CN1970543A Synthesis and uses of serial ion liquid as candidate drug with anticancer activity
05/30/2007CN1970541A Method for preparing 3,5,6-trichloro pyridine-2-sodium alcoholate without solvent
05/30/2007CN1318431C Process for production of heteroaryl-type boron compounds with iridium catalyst
05/30/2007CN1318408C Azo hetercyle beta-elemene derivative and its preparation method and uses
05/30/2007CN1318405C Azo heterocycle beta-elemene piperazine alkyl derivative and its preparation and uses
05/30/2007CN1318404C Aryl ureas as kinase inhibitors
05/30/2007CN1318393C Process for the preparation of 4-haloalkylnicotinonitriles
05/30/2007CN1318389C Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
05/30/2007CN1318388C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
05/29/2007US7223879 Reactibng transition metal with boron compound and sulfonate compound
05/29/2007US7223868 Heteroaromatic glucokinase activators
05/29/2007US7223794 For example, 2-{[(1S)-2-amino-1-phenylethyl]oxy}-4-chloro-5-fluorobenzonitrile; use in treatment or prophylaxis of inflammatory diseases and CNS diseases
05/29/2007US7223791 Function regulator for retinoid relative receptor
05/29/2007US7223780 Triazole-derivatives as blood clotting enzyme factor Xa inhibitors
05/29/2007US7223778 5-substituted-2-arylpyridines
05/29/2007US7223774 Benzamide 2-hydroxy-3-diaminoalkanes
05/29/2007US7223764 Antilipemic agents; anticholesterol agents
05/29/2007US7223355 Functional additive having UV-absorbing substituent and ink composition containing the same
05/24/2007WO2007059157A1 Bisamide inhibitors of hedgehog signaling
05/24/2007WO2007059015A1 Improved catalysts for alpha-olefin manufacture
05/24/2007WO2007058927A1 Histone deacetylase inhibitors as therapeutics for neurological diseases
05/24/2007WO2007057139A1 Microbiocides
05/24/2007WO2007024860A3 Sulfonamides
05/24/2007WO2006071960A3 Compositions and methods of treating cell proliferation disorders
05/24/2007US20070117984 catalyst selectivity for cyanation or ammoxidation; produce 3-cyanopyridine from 3-methylpyridine by reacting with ammonia and oxygen and in presence of catalysts which contain transition metals in addition to vanadium and phosphorus, and a catalyst support
05/24/2007US20070117852 (Hetero)cyclyl carboxanilides for controlling harmful fungi
05/24/2007US20070117848 e.g. 2-Carboxy-3-benzyloxy-6-methyl-pyran-4(1H)-one; matrix metalloproteinase inhibitors, histone deacetylase inhibitors, or anthrax lethal factor inhibitors; cell growth and division, bone growth, wound healing, embryogenesis, angiogenesis; cardiovascular disease, stroke, arthritis, tumor metastasis
05/24/2007US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
05/24/2007US20070117822 Novel antimalarial baylis-hillman adducts and a process for the preparation thereof
05/24/2007US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B
05/24/2007US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis
05/24/2007US20070117761 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof